Intervention

Stereotactic Radiation Therapy

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions7

Lead sponsors shown3

Clinical trials

3 shown

SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast CancersNCT07844759 · 2027-01-01

NOT_YET_RECRUITING

SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLCNCT07818304 · 2026-10-01

NOT_YET_RECRUITING

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain MetastasesNCT04889066 · 2024-10-01

WITHDRAWN

Common conditions

Brain Metastases from Non-small Cell Lung Cancer1 Breast Cancer1 Early-Stage Breast Carcinoma1 HER2-Negative Breast Cancer1 Hormone Receptor-Positive Breast Cancer1 Lung Neoplasms1 Non Small Cell Lung Cancer1

Leading sponsors

Renaissance Institute of Precision Oncology and Radiosurgery1 The First People's Hospital of Lianyungang1 University of Texas Southwestern Medical Center1

Trial status mix

NOT_YET_RECRUITING2

WITHDRAWN1

Phase mix

PHASE22

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.